TY 51469

Known as: TY-51469, TY51469 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2017
01220072017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
AIM To investigate the effect of chymase inhibitor TY-51469 in the therapy of inflammatory bowel disease and the underlying… (More)
Is this relevant?
2015
2015
Important structural differences imply that human and mouse mast cell chymases may differ with respect to their enzymatic… (More)
Is this relevant?
2014
2014
OBJECTIVE To clarify the role of chymase in hypertension, we evaluated the effect of a chymase inhibitor, TY-51469, on vascular… (More)
Is this relevant?
2012
2012
Mechanism(s) of cisplatin-induced acute renal failure, as manifested by increases in blood urea nitrogen and creatinine, was… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Chymase is a chymotrypsin-like serine protease that is present in mast cells. Its activities include various effects associated… (More)
Is this relevant?
2010
2010
AIM Mast cells may be involved in the pathogenesis of nonalcoholic steatohepatitis (NASH). The mast cell protease chymase… (More)
Is this relevant?
2010
2010
The side effects of nonsteroidal anti-inflammatory drugs (NSAIDs) include gastrointestinal damage not only in the stomach but… (More)
  • figure 3
  • figure 1
  • figure 2
  • figure 4
  • figure 6
Is this relevant?
2010
2010
AIM Chymase converts angiotensin I to angiotensin II, which may promote the development of liver fibrosis. In this study, whether… (More)
Is this relevant?
2009
2009
Angiotensin II may be involved in pancreatic disorganization, but the involvement of chymase has been unclear. In the present… (More)
Is this relevant?
2007
2007
Chymase has been known as a local angiotensin II-generating enzyme in the cardiovascular system in dogs, monkeys, hamsters, and… (More)
Is this relevant?